Moderna Researches Hantavirus Vaccine Amid Outbreak, Stock Surges
Moderna Inc. is actively researching potential vaccines to protect against hantaviruses, a deadly pathogen. These early-stage efforts are being conducted in collaboration with the US Army Medical Research Institute of Infectious Diseases and Korea University College of Medicine. This initiative underscores Moderna’s commitment to developing countermeasures for emerging infectious diseases, even as public health experts suggest the current risk from a cruise ship outbreak is minimal.
John Q. Hosedrinker